Podcasts

Episode 44 | Large Cell Neuroendocrine Carcinoma of the Lung: Challenges in Diagnosis and Treatment

A/Prof Rachel Wong is joined by Dr Patrick Hosking, Dr Mal Itchins, and Dr Sagun Parakh discuss the diagnostic markers when identifying LC-NEC.

Episode Summary

In this episode, we discuss the clinical and diagnostic markers when identifying a rare sub type of NSCLC, large-cell neuroendocrine carcinomas (LC-NEC), and provide insights into the management of these patients and future treatment developments.

This podcast episode is sponsored by Boehringer Ingelheim. 

 Show Hosts

  • A/Prof Rachel Wong, Deputy Director Oncology Eastern Health and Medical Oncologist at Epworth East in Melbourne
  • Dr Patrick Hosking, Senior Histopathologist at Eastern Health Pathology
  • Dr Mal Itchins, Thoracic Medical Oncologist at Royal North Shore Hospital and Chris O’Brien LifeHouse in Sydney
  • Dr Sagun Parakh, Medical Oncologist at the Austin Hospital, Lung Cancer Lead

Play Episode 44 | Large Cell Neuroendocrine Carcinoma of the Lung: Challenges in Diagnosis and Treatment

More Podcasts

Host A/Prof Mel Moore interviews Dr Jazmin Eckhaus, a practising surgeon in the subspecialty of thoracic surgery.
Host A/Prof Adnan Nagrial leads a panel discussing the clinical implications of the broad PBS listing of ipilimumab and nivolumab in Australia.
Host A/Prof Deme Karikios leads a panel discussion focusing on the recent, groundbreaking broad PBS listing of certain immunotherapy agents in Australia.
Host A/Prof Rachel Roberts-Thomson leads a panel discussion focusing on the landscape of BRAF-mutated non-small cell lung cancer.
In this episode of TOGA's Conversations in Lung Cancer Research, host A/Prof Malinda Itchins, a medical oncologist and clinician researcher at Royal North Shore Hospital
In this episode, we welcome A/Prof Surein Arulananda, the interim Director of Medical Oncology and Thoracic Oncology Trials Lead at Monash Health.